Benefit–Risk Assessment of Rosuvastatin in the Treatment of Atherosclerosis and Related Diseases
Crossref DOI link: https://doi.org/10.1007/s40264-014-0169-4
Published Online: 2014-05-01
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kostapanos, Michael S.
Rizos, Christos V.
Elisaf, Moses S.
Text and Data Mining valid from 2014-05-01